HIGHLIGHTS
- who: Kathleen M. Gorman and colleagues from the United States United States have published the article: The Usefulness of a Targeted Next Generation Sequencing Gene Panel in Providing Molecular Diagnosis to Patients With a Broad Spectrum of Neurodevelopmental Disorders, in the Journal: (JOURNAL)
- what: The aim of this study was to evaluate the clinical usefulness of a 221-gene custom panel in a cohort of 338 individuals with a broad spectrum of NDDs.
- how: This result can be considered a success as the cohort includes individuals with heterogeneous clinical outcomes which limits the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.